Healthcare and Life Sciences

Format: 2017-01-20
Format: 2017-01-20
January 11, 2017 | 83 Pages | SKU: IRTNTR11506

Overview of the global genomics biomarkers market

The global genomics biomarkers market is anticipated to grow at a steady rate and will post a CAGR of close to 18% during the forecast period. The increasing instances of low-cost clinical trials in developing countries will drive the growth prospects for the global genomics biomarkers market until the end of 2021. This globalization of clinical trials has been credited to numerous components that include organized trials, the willingness of members facilitating the enrollment, accessibility of qualified local investigators, enhanced opportunities in various Tier 2 and Tier 3 countries, and lower expenses of clinical trials in developing nations. Some of the other factors responsible for the increasing preference for disease-based genomic biomarkers testing includes the faster and precise analysis of diseases and potential lowering in volume and time involved in clinical trials.

In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market for the next four years. One of the major factor responsible for the market’s growth in the region is clinical research activities provided by a large number of manufacturers and distributors to other countries such as Brazil, Mexico, and few Tier 3 countries. According to the industry research report, increasing investments in the healthcare sector to provide the highest quality and effective treatment will drive the market’s growth in the region during the forecasted region.

Competitive landscape and key vendors

The global genomics biomarkers market is highly competitive and fragmented due to the presence of a large number of vendors across the globe. These vendors increasingly form partnerships to develop


January 11, 2017 | 70 Pages | SKU: IRTNTR11103

Overview of the interventional spine devices market in the US

Technavio’s market research analyst predicts the interventional spine devices market in the US to grow steadily at a CAGR of above 8% by 2021. One of the primary drivers for this market is the rise in the incidence of spine and bone disorders. The most common spinal disorders include spondylolisthesis, DDC, herniated discs, prolapsed intervertebral disc, and spinal stenosis. Also, osteoporosis can cause degenerative changes in the spinal discs including intervertebral discs and spinal facets that require surgical intervention. This bone disorder can increase bone porosity, fragility, and make bones weaker, making them susceptible to fractures. Interventional procedures help reduce pain, improve bone stability, and increase life expectancy. The growing incidences of spine and bone disorders will drive the adoption of interventional spine procedures during the forecast period.

One of the latest trends gaining traction in this market is the shift in physician preference for minimally invasive (MI) procedures. The advancements in spinal interventions has led to an increase in the number of clinical trials and launch of new products in the market. The demand for rapid recovery reduced hospital stays, and better patient outcome resulted in many medical facilities conducting spinal fusion surgery to repair the vertebrae and treat painful conditions of the spine. Moreover, owing to its increased ability to treat spinal disorders such as spinal tumors,


January 10, 2017 | 114 Pages | SKU: IRTNTR11470

Overview of the global interventional spine devices market

Technavio’s market research analyst predicts the global interventional spine devices market to grow steadily at a CAGR of above 10% by 2021. One of the key factors responsible for this market growth is the increasing number of incidences of spine and bone disorders. There has been a significant rise in the incidence of spinal disorders across the world over the last decade. The most common spinal disorders include spondylolisthesis, degenerative disc disease, herniated discs, prolapsed intervertebral disc, and spinal stenosis. Disc herniation is a result of age-related degeneration of the annulus fibrosis or trauma, lifting injuries, or straining. Also, osteoporosis can lead to degenerative changes in the spinal discs, including intervertebral discs and spinal facets that require surgical intervention.

In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market for the next few years. Owing to the widespread adoption of minimally invasive and non-invasive techniques the Americas is dominating the interventional spine devices market. The US is the largest revenue contributor to this region due to the increased use of interventional spine surgery. Other major growth drivers for the Americas include the existence of transparent reimbursement policies, high disposable incomes, and high awareness about vertebral compression fracture


January 03, 2017 | 95 Pages | SKU: IRTNTR11374

Overview of the global optical imaging market

The global optical imaging market is anticipated to grow at a steady rate and will post a CAGR of more than 8% during the forecast period. The increasing market penetration of digital technologies in the optical imaging and medical imaging areas will drive the growth prospects for the global optical imaging market over the next four years. According to the global market research, the application of laser technology includes optical imaging, medical imaging, and microscopy. Also, to increase the process efficiency, the optics and photonics technology is integrated to develop advanced optical imaging systems. Furthermore, the radiation-free Optical Coherence Tomography (OCT) technology is used for dental diagnosis and treatment, whereas, the sound navigation and ranging (SONAR) technology are used for capturing images as a part of digital technology in the medical imaging process.

In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market until the end of 2021.         One of the major factors responsible for the increasing number of installations of optical imaging systems is the continual demand from North America that holds the largest market share in the region. Also, according to the industry research report, the adoption rate of optical imaging systems in the US clinics and operating rooms is witnessed to be very high. Moreover, the rate of adoption of these devices is high because they are cost-effectiveness and have non-invasive nature. Furthermore, the developing public-private partnerships would reduce the overall healthcare expenditure, which would boost the influx of end users and accelerate the market’s growth


January 02, 2017 | 115 Pages | SKU: IRTNTR11341

Overview of the global left atrial appendage (LAA) closure market

The global LAA closure market is anticipated to grow rapidly and post a CAGR of more than 33% during the forecast period. The increasing number of product approvals will drive the growth prospects for the global LAA closure market until the end of 2021. One of the major factors responsible for the increasing product approvals is the rising number of research activities by vendors. For instance, in March 2015, Boston Scientific received the US FDA approval of WATCHMAN device that consists of a catheter delivery system and is used to implant the device permanently in the LAA of the heart. Furthermore, in June 2016, AtriCure, received approval from the Ministry of Health, Labour and Welfare (MHLW) for its AtriClip products that include AtriClip Standard and the AtriClip Pro devices.

In terms of geography, EMEA accounted for the maximum market share in 2016 and will continue to dominate the market during the next few years. It has been observed that favorable guidelines for manufacturers and the increased awareness among physicians drives the adoption rate of LAA closure devices in the region. Also, the growing clinical trials produce high-quality data that further drives the adoption of LAA closure in EMEA.

Competitive landscape and key vendors

The global LAA closure market is in the nascent stage and has a presence of few key players that offer commercial products in the market. Since the market witnesses a stringent regulatory environment, new entrants find it difficult to enter the market.

Key vendors in this market are -

  • AtriCure
  • Boston Scientific
  • Coherex Medical
  • St. Jude Medical

Other prominent vendors in the market include Occlutech, Lifetech Scientific, and SentreHEART.

Segmentation by product


December 30, 2016 | 128 Pages | SKU: IRTNTR11316

Overview of the global protein therapeutics market

Market research analysts at Technavio predict that the global protein therapeutics market will grow steadily during the next four years and post a CAGR of almost 8% by 2021. This market research analysis identifies the increased demand for monoclonal antibodies (mAbs) as one of the primary growth factors for this market. mAbs accounts for a major share of protein therapeutics. The increasing usage of mAbs in various therapies such as radioimmunotherapy and antibody-directed enzyme prodrug therapy will drive the growth of the market. Additionally, mAbs are also used in the formulation of biopharmaceutical drugs for the treatment of different diseases including cancer and ulcerative colitis which will also aid in the market’s growth in the coming years.

This market research and analysis estimates that in terms of geographical regions, the Americas will be the major revenue contributor to the market throughout the forecast period. Factors such as the increase in uptake of the existing protein therapeutics and the rise in approvals for certain formulations that will induce more vendors to conduct R&D activities and enter the market, will boost the market’s growth prospects in this region.  

Competitive landscape and key vendors

The market is highly competitive and consists of numerous small and large-scale vendors who operate at a local or global scale. To enhance their global reach and increase revenue shares, vendors have started forming strategic alliances to manufacture and market drugs. Companies engaged in manufacturing and marketing protein therapeutics that can effectively treat various disorders will gain a competitive edge over the other vendors in the market. The market’s growth


Pages